Table 1 The expression levels of hTid-1 in different patient cancer samples and how it affects the prognosis of those cancer patients
From: Putting human Tid-1 in context: an insight into its role in the cell and in different disease states
S. No | Disease | Patient samples | Expression | Processes affected | Survival rate | References |
|---|---|---|---|---|---|---|
1 | Head and neck squamous cell carcinoma | 47 HNSCC biopsies | Low | Tumor differentiation | Poor | Chen et al. [27] |
2 | Lung adenocarcinoma | 55 patient tumor samples | High | Tumor growth | Better | Chen et al. [61] |
3 | Non-small cell lung cancer | 20 surgically resected Tumor samples | Low | – | Poor | Chen et al. [61] |
4 | Non-small cell lung cancer | NSCLC patient samples | Low Tid1L | Tumorigenesis | Poor | Chen et al. [39] |
5 | Non-small cell lung cancer | Tumor samples from Stage-IV NSCLC patients | High Tid1S | Metastasis and invasion | Poor | Wang et al. [30] |
6 | Hepatocellular carcinoma | 210 surgically resected HCC specimens | Low | Recurrence of HCC | Poor | Chen et al. [106] |